Evaluation of Central Sensitisation in Bladder Pain Syndrome: A Systematic Review.
Bladder pain syndrome
Central sensitization
Chronic pain
Pathophysiology
Quantitative sensory testing
Journal
International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041
Informations de publication
Date de publication:
07 May 2024
07 May 2024
Historique:
received:
17
10
2023
accepted:
27
03
2024
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
aheadofprint
Résumé
Bladder pain syndrome (BPS) is a debilitating condition characterised by exaggerated bladder sensations and altered bladder function. It is still unknown whether the condition is a peripheral sensory problem or due to abnormal central sensory processing as seen in central sensitisation. This systematic review, which followed a published and Prospective Register of Systematic Reviews-registered protocol (CRD42021229962), is aimed at establishing the scope of central sensitisation in patients with BPS to aid optimal management and treatment. Four databases were searched, and appraisal of the identified studies was conducted by two independent reviewers based on eligibility criteria: patients with BPS being investigated for central sensitisation with or without comparison of controls, English-language articles, full text and publication in a peer-reviewed journal. The Methodological Index for non-Randomised Studies was used to determine study quality. We identified 763 papers in total, with 15 studies included in the final analysis. All studies were observational and had a low risk of bias. Measures included in the evaluation of CS were questionnaires, urodynamics, and quantitative sensory testing methods. There was evidence of central sensitisation in patients with BPS in all papers evaluated (15 out of 15). In addition, more significant central sensitisation correlated with severe disease presentation (3 out of 3 papers) and concomitant chronic pain conditions (5 out of 5 papers). Central sensitisation plays an integral role in BPS patient pathology. Many secondary measures are used to evaluate this condition. Stratification of patients based on their pathology (peripheral, central or a combination of the two) will aid in implementing an individualised management strategy.
Identifiants
pubmed: 38713239
doi: 10.1007/s00192-024-05793-5
pii: 10.1007/s00192-024-05793-5
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The International Urogynecological Association.
Références
Offiah I, McMahon SB, O’Reilly BA. Interstitial cystitis/bladder pain syndrome: diagnosis and management. Int Urogynecol J. 2013;24(8):1243–58.
pubmed: 23430074
doi: 10.1007/s00192-013-2057-3
Doggweiler R, Whitmore KE, Meijlink JM, et al. A standard for terminology in chronic pelvic pain syndromes: a report from the chronic pelvic pain working group of the international continence society. Neurourol Urodyn. 2017;36(4):984–1008.
pubmed: 27564065
doi: 10.1002/nau.23072
Offiah I, Didangelos A, Dawes J, et al. The expression of inflammatory mediators in Bladder Pain Syndrome. Eur Urol. 2016;70(2):283–90.
pubmed: 26965559
pmcid: 4926725
doi: 10.1016/j.eururo.2016.02.058
Wall PD, McMahon SB, Koltzenburg M. Wall and Melzack’s textbook of pain. 5th edn. Philadelphia: Elsevier/Churchill Livingstone. 2006.
Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139:267–84.
pubmed: 19837031
pmcid: 2852643
doi: 10.1016/j.cell.2009.09.028
Latremoliere A, Woolf CJ. Central sensitisation: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.
pubmed: 19712899
pmcid: 2750819
doi: 10.1016/j.jpain.2009.06.012
Woolf CJ. Central sensitisation: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–15.
pubmed: 20961685
doi: 10.1016/j.pain.2010.09.030
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA group. BMJ. 2009;339:b2535.
pubmed: 19622551
pmcid: 2714657
doi: 10.1136/bmj.b2535
Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological index for non-randomised studies (MINORS): development and validation of a new instrument. ANZ J Surg. 2003;73:712–6.
pubmed: 12956787
doi: 10.1046/j.1445-2197.2003.02748.x
Lai HH, Newcomb C, Harte S, et al. Comparison of deep phenotyping features of UCPPS with and without Hunner lesion: a MAPP-II Research Network Study. Neurourol Urodyn. 2021;40:810–8.
pubmed: 33604963
pmcid: 8159180
doi: 10.1002/nau.24623
Hellman KM, Roth GE, Dillane KE, et al. Dysmenorrhea subtypes exhibit differential quantitative sensory assessment profiles. Pain. 2020;161:1227–36.
pubmed: 32168005
pmcid: 7230023
doi: 10.1097/j.pain.0000000000001826
Thu JHL, Vetter J, Lai HH. The severity and distribution of non-urologic pain and urogenital pain in overactive bladder are intermediate between interstitial cystitis and controls. Urology. 2019;130:59–64.
pubmed: 31034917
doi: 10.1016/j.urology.2019.03.030
Offiah I, Dilloughery E, McMahon SB, O’Reilly BA. Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome. Int Urogynaecol J. 2019;30:1293–301.
doi: 10.1007/s00192-019-03892-2
Harte SE, Schrepf A, Gallop R, et al. Quantitative assessment of non-pelvic pressure pain sensitivity in urologic chronic pelvic pain syndrome: a MAPP research network study. Pain. 2019;160(6):1270–80.
pubmed: 31050659
pmcid: 6527452
doi: 10.1097/j.pain.0000000000001505
Cervigni M, Onesti E, Ceccanti M, et al. Repetitive transcranial magnetic stimulation for chronic neuropathic pain in patients with bladder pain syndrome/interstitial cystitis. Neurourol Urodyn. 2018;37:2678–87.
pubmed: 29797500
doi: 10.1002/nau.23718
Grinberg K, Granot M, Lowenstein L, Abramov L, Weissman-Fogel I. A common pronociceptive pain modulation profile typifying subgroups of chronic pelvic pain syndromes is interrelated with enhanced clinical pain. Pain. 2017;158:1021–9.
pubmed: 28178074
doi: 10.1097/j.pain.0000000000000869
Chelimsky G, Simpson P, McCabe N, Zhang L, Chelimsky T. Autonomic testing in women with chronic pelvic pain. J Urol. 2016;196(2):429–34.
pubmed: 27026035
pmcid: 4969223
doi: 10.1016/j.juro.2016.03.142
Schrepf A, Bradley CS, O’Donnell M, et al. Toll-like receptor 4 and comorbid pain in interstitial cystitis/bladder pain syndrome: a multidisciplinary approach to the study of chronic pelvic pain research network study. Brain Behav Immun 2015;49:66–74.
pubmed: 25771510
pmcid: 4567436
doi: 10.1016/j.bbi.2015.03.003
Lai HH, Gardner V, Ness TJ, Gereau RW IV. Segmental hyperalgesia to mechanical stimulus in interstitial cystitis/bladder pain syndrome: evidence of central sensitization. J Urol. 2014;191(5):1294–9.
pubmed: 24316091
doi: 10.1016/j.juro.2013.11.099
Ness TJ, Lloyd LK, Fillingim RB. An endogenous pain control system is altered in subjects with interstitial cystitis. J Urol. 2014;191(2):364–70.
pubmed: 23973521
doi: 10.1016/j.juro.2013.08.024
Seth A, Teichman JMH. Differences in the clinical presentation of interstitial cystitis/painful bladder syndrome in patients with or without sexual abuse history. J Urol. 2008;180:2029–33.
pubmed: 18804240
doi: 10.1016/j.juro.2008.07.053
Clauw DJ, Schmidt M, Radulovic D, Singer A, Katz P, Bresette J. The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res. 1997;31:125–31.
pubmed: 9201654
doi: 10.1016/S0022-3956(96)00051-9
Sanses T, McCabe P, Zhong L, et al. Sensory mapping of pelvic dermatomes in women with interstitial cystitis/bladder pain syndrome. Neurourol Urodyn. 2018;37:458–65.
pubmed: 28628232
doi: 10.1002/nau.23330
Warren JW, Langenberg P, Greenberg P, Diggs C, Jacobs S, Wesselmann U. Sites of pain from interstitial cystitis/painful bladder syndrome. J Urol. 2008;180:1373–7.
pubmed: 18707715
doi: 10.1016/j.juro.2008.06.039
Kindler LL, Bennett RM, Jones KD. Central sensitivity syndromes: mounting pathophysiologic evidence to link fibromyalgia with other common chronic pain disorders. Pain Manag Nurs. 2011;12(1):15–24.
pubmed: 21349445
doi: 10.1016/j.pmn.2009.10.003
Martínez-Martínez L-A, Mora T, Vargas A, Fuentes-Iniestra M, Martínez-Lavín M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis. J Clin Rheumatol. 2014;20(3):146–50.
pubmed: 24662556
doi: 10.1097/RHU.0000000000000089
Adams LM, Turk DC. Psychological factors and central sensitivity syndromes. Curr Rheumatol Rev. 2015;11(2):96–108.
pubmed: 26088211
pmcid: 4728142
doi: 10.2174/1573397111666150619095330
Jutzeler CR, Curt A, Kramer JL. Relationship between chronic pain and brain reorganisation after deafferentation: a systematic review of functional MRI findings. Neuroimage Clin. 2015;9:599–606.
pubmed: 26740913
pmcid: 4644246
doi: 10.1016/j.nicl.2015.09.018
Neblett R, Hartzell MM, Cohen H, Mayer TG, Williams M, Choi YH. Ability of the central sensitization inventory to identify central sensitivity syndromes in an outpatient chronic pain sample. Clin J Pain. 2014;31(4):323–32.
doi: 10.1097/AJP.0000000000000113
Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol. 2014;13(9):924–35.
pubmed: 25142459
doi: 10.1016/S1474-4422(14)70102-4
Matsuda M, Huh Y, Ji R. Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain. J Anesth. 2019;33(1):131–9.
pubmed: 30448975
doi: 10.1007/s00540-018-2579-4
Aguggia M, Saracco MG, Cavallini M, Bussone G, Cortelli P. Sensitization and pain. Neurol Sci. 2013;34(Suppl 1):S37–40.
pubmed: 23695043
doi: 10.1007/s10072-013-1382-0
Smart KM, Blake C, Staines A, Thacker S, Doody C. Mechanisms-based classifications of musculoskeletal pain: part 1 of 3: symptoms and signs of central sensitisation in patients with low back (+/− leg) pain. Man Ther. 2012;17(4):336–44.
pubmed: 22534654
doi: 10.1016/j.math.2012.03.013
Peters KM, Killinger KA, Mounayer MH, Boura JA. Are ulcerative and non-ulcerative interstitial cystitis/painful bladder syndrome 2 distinct diseases? A study of coexisting conditions. Urology. 2011;78:301–8.
pubmed: 21703668
doi: 10.1016/j.urology.2011.04.030
Akiyama Y. Biomarkers in interstitial cystitis/bladder pain syndrome with and without Hunner Lesions: a review and future perspectives. Diagnostic. 2021;11(2):2238.
doi: 10.3390/diagnostics11122238
Warren JW, Howard FM, Cross RK, et al. Antecedent nonbladder syndromes in case-control study of interstitial cystitis/painful bladder syndrome. Urology. 2009;73:52–7.
pubmed: 18995888
doi: 10.1016/j.urology.2008.06.031
Molokie RE, Wang ZJ, Yao Y, et al. Sensitivities to thermal and mechanical stimuli: adults with sickle cell disease compared to healthy, pain-free African American controls. J Pain. 2020;21(9–10):957–67.
pubmed: 31733363
doi: 10.1016/j.jpain.2019.11.002
Yarnitsky D, Bouhassira D, Drewes AM, et al. Recommendations on practice of conditioned pain modulation (CPM) testing. Eur J Pain. 2015;19(6):805–6.
pubmed: 25330039
doi: 10.1002/ejp.605
Granovsky Y. Conditioned pain modulation: a predictor for development and treatment of neuropathic pain. Curr Pain Headache Rep. 2013;17(9):361.
pubmed: 23943407
doi: 10.1007/s11916-013-0361-8
Bourke JH, Wodehouse T, Clark LV, et al. Central sensitisation in chronic fatigue syndrome and fibromyalgia; a case control study. J Psychosom Res. 2021;150:110624.
pubmed: 34600309
doi: 10.1016/j.jpsychores.2021.110624
Hamid P, Malik BH, Hussain ML. Noninvasive transcranial magnetic stimulation (TMS) in chronic refractory pain: a systematic review. Cureus. 2019;11(10):e6019.
pubmed: 31824787
pmcid: 6886641
Harte SE, Harris RE, Claw DJ. Neurobiol central sensitisation. J Appl Biobehav Res. 2018;23:e12137.
doi: 10.1111/jabr.12137